Michael T Byrne

7PUBLICATIONS
41CO-AUTHORS
Molecular targetsGene and molecular therapyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 09, 2026
Selinexor and Venetoclax Combination in Patients With Relapsed or Refractory Acute Myeloid Leukemia.

Somedeb Ball, Farrukh T Awan, Ben K Tomlinson

|Apr 10, 2023
PI3K Inhibition Restores and Amplifies Response to Ruxolitinib in Patients with Myelofibrosis.

Tamara K Moyo, Ashwin Kishtagari, Matthew T Villaume

|Jul 11, 2022
Eprenetapopt Plus Azacitidine After Allogeneic Hematopoietic Stem-Cell Transplantation for TP53-Mutant Acute Myeloid Leukemia and Myelodysplastic Syndromes.

Asmita Mishra, Roni Tamari, Amy E DeZern

|May 12, 2020
The use of venetoclax-based salvage therapy for post-hematopoietic cell transplantation relapse of acute myeloid leukemia.

Michael Byrne, Nathalie Danielson, Salyka Sengsayadeth

Pageof 2